Over half of the sample attained opioids through their own prescription, and 47.2% of patients with co-occurring sedative use disorder attained sedatives by prescription.
Healthcare professionals see the benefits of prescribing cannabis therapies but report significant knowledge gaps in both recreational and medical cannabis.
A recent Morbidity and Mortality Weekly Report highlights the risks associated with use of OTC products containing undeclared prescription ingredients as well as the importance of collaboration between various health departments and systems to ensure a prompt response to an outbreak.
The list of conditions that put people at risk for severe COVID-19 illness has been expanded by the US CDC.
High level internal attribution bias and dysfunctional attitudes, when combined with a tendency to use drugs or alcohol as a coping mechanism, may affect patients’ willingness to use proactive coping efforts.
In 2015 to 2018, 10.7% of US adults aged 20 years or older used one or more prescription pain medications in the previous 30 days.
Clinicians should consider whether a race correction will relieve or exacerbate inequities, according to editorialists.
Researchers sought to examine national- and county-level buprenorphine prescription patterns by patient demographics and clinician specialty, and county-level characteristics associated with buprenorphine dispensing.
The FDA has issued warning letters to several companies selling unapproved injectable products labeled as homeopathic.
One-third of trials do not include clinical end points; 97 randomized trials were open-label design
